01 1SMS Pharmaceuticals
01 1HYDROXYCHLOROQUINE SULFATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-06-28
Pay. Date : 2022-06-13
DMF Number : 37131
Submission : 2022-05-19
Status : Active
Type : II
20
Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is HYDROXYCHLOROQUINE SULFATE USP, with a corresponding US DMF Number 37131.
Remarkably, this DMF maintains an Active status since its submission on May 19, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 28, 2022, and payment made on June 13, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
